MRC1 and cancer: Among MMR gene mutation carriers, cancer-affected individuals showed faster telomere attrition with age (r = −0.344; p = 2.4×10−5) than cancer-free carriers (r = −0.094; p = 0.351) (for the difference, p = 0.045) (Figure 3B).